MCK
52
2
IRM
31
3
PCG
50
5
SHW
58
2
STX
73
-2
GLW
49
3
EQR
37
3
SWK
39
-10
EIX
42
5
CVS
58
-2
FE
35
-2
PSX
57
-7
CLX
55
4
PG
37
2
RHI
27
2
AIV
51
3
SLB
42
-2
HCA
44
-4
ECL
59
5
A
48
2
MCK
52
2
IRM
31
3
PCG
50
5
SHW
58
2
STX
73
-2
GLW
49
3
EQR
37
3
SWK
39
-10
EIX
42
5
CVS
58
-2
FE
35
-2
PSX
57
-7
CLX
55
4
PG
37
2
RHI
27
2
AIV
51
3
SLB
42
-2
HCA
44
-4
ECL
59
5
A
48
2
Financhill
Back

Bioceres Crop Solutions 10K Form

Sell
5

BIOX
Bioceres Crop Solutions

Last Price:
$3.80
Seasonality Move:
-4.13%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BIOX News And Ratings

See the #1 stock for the next 7 days that we like better than BIOX

BIOX Financial Statistics

Sales & Book Value

Annual Sales: $464.8M
Cash Flow: $20.2M
Price / Cash Flow: 8.59
Annual Sales: $5.12
Price / Book: 0.74

Profitability

EPS (TTM): -0.14530
Net Income (TTM): $-9.1M
Gross Margin: $182.4M
Return on Equity: -2.61%
Return on Assets: -1.09%

Bioceres Crop Solutions Earnings Forecast

Key Bioceres Crop Solutions Financial Ratios

  • The Gross Profit Margin over the past 11 years for BIOX is 39.25%.
  • The Selling, General & Administrative Expenses for BIOX have been equal to 20.28% of Gross Profit Margin.
  • The Research & Development expenses have been 3.70% of Revenue.
  • The Interest Expense is 743.82% of Operating Income.
  • The Net Earning history of BIOX is 0.70% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 4 years.

Bioceres Crop Solutions Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Chemicals
Sector: Materials
Current Symbol: BIOX
CUSIP: G1117K
Website: biocerescrops.com

Debt

Debt-to-Equity Ratio: 0.83
Current Ratio: 1.02
Quick Ratio: 0.72

Price-to-Earnings

Trailing P/E Ratio: 74.56
Forward P/E Ratio: 9.29

BIOX Technical Analysis vs Fundamental Analysis

Sell
5
Bioceres Crop Solutions (BIOX) is a Sell

Is Bioceres Crop Solutions a Buy or a Sell?